Comprehensive Stock Comparison
Compare Cigna Corporation (CI) vs UnitedHealth Group Incorporated (UNH) Stock
Analyze side-by-side fundamentals, valuation, growth, and profitability to decide which stock is the better buy.
Selected Stocks
Add up to 10 tickers. Use presets or search to get started.
Quick Verdict
| Category | Winner | Why |
|---|---|---|
| Growth | CI | 26.6% revenue growth vs UNH's 11.8% |
| Value | CI | Lower P/E (9.6x vs 16.4x) |
| Quality / Margins | UNH | 3.2% net margin vs CI's 2.3% |
| Stability / Safety | CI | Beta 0.19 vs UNH's 0.28 |
| Dividends | UNH | 5.2% yield, 25-year raise streak, vs CI's 1.9% |
| Momentum (1Y) | CI | -4.2% vs UNH's -36.4% |
| Efficiency (ROA) | UNH | 4.6% ROA vs CI's 3.9%, ROIC 9.3% vs 10.5% |
Who Each Stock Is For
Income & stability
Growth exposure
Long-term compounding (10Y)
Sleep-well-at-night portfolio
Defensive / Recession hedge
Business Model
What each company does and how it makes money
Cigna is a diversified healthcare services company that operates through two main segments: Cigna Healthcare (insurance plans) and Evernorth (pharmacy benefits and health services). It generates revenue primarily from insurance premiums (around 60% from Cigna Healthcare) and pharmacy services/benefits management fees (roughly 40% from Evernorth). The company's competitive advantage lies in its integrated healthcare ecosystem—combining insurance coverage with pharmacy benefits management and health services—which creates cross-selling opportunities and operational efficiencies.
UnitedHealth Group is a diversified healthcare company that operates both health insurance plans and healthcare services businesses. It generates revenue primarily through health insurance premiums (UnitedHealthcare segment) and healthcare services including pharmacy benefits management, data analytics, and care delivery (Optum segments). The company's key advantage is its integrated model—combining insurance with healthcare services—which creates data synergies and vertical integration moats.
Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Financial Metrics Comparison
Side-by-side fundamentals across 2 stocks. BestLagging
Financial Scorecard
CI leads in 4 of 6 categories (Valuation Metrics, Profitability & Efficiency). UNH leads in 2 (Financial Metrics, Analyst Outlook).
Financial Metrics (TTM)
UNH is the larger business by revenue, generating $447.6B annually — 1.7x CI's $268.1B. Profitability is closely matched — net margins range from 3.2% (UNH) to 2.3% (CI).
| Metric | CICigna Corporation | UNHUnitedHealth Grou… |
|---|---|---|
| RevenueTrailing 12 months | $268.1B | $447.6B |
| EBITDAEarnings before interest/tax | $11.9B | $23.3B |
| Net IncomeAfter-tax profit | $6.1B | $14.2B |
| Free Cash FlowCash after capex | $7.4B | $32.0B |
| Gross MarginGross profit ÷ Revenue | +10.0% | +18.5% |
| Operating MarginEBIT ÷ Revenue | +3.4% | +4.2% |
| Net MarginNet income ÷ Revenue | +2.3% | +3.2% |
| FCF MarginFCF ÷ Revenue | +2.8% | +7.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +9.5% | +12.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +165.0% | -59.9% |
Valuation Metrics
At 18.8x trailing earnings, UNH trades at a 21% valuation discount to CI's 23.9x P/E. On an enterprise value basis, CI's 9.0x EV/EBITDA is more attractive than UNH's 13.5x.
| Metric | CICigna Corporation | UNHUnitedHealth Grou… |
|---|---|---|
| Market CapShares × price | $76.4B | $265.7B |
| Enterprise ValueMkt cap + debt − cash | $100.8B | $315.9B |
| Trailing P/EPrice ÷ TTM EPS | 23.91x | 18.82x |
| Forward P/EPrice ÷ next-FY EPS est. | 9.57x | 16.43x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 9.02x | 13.54x |
| Price / SalesMarket cap ÷ Revenue | 0.31x | 0.59x |
| Price / BookPrice ÷ Book value/share | 1.99x | 2.62x |
| Price / FCFMarket cap ÷ FCF | 8.52x | 8.30x |
Profitability & Efficiency
CI delivers a 14.6% return on equity — every $100 of shareholder capital generates $15 in annual profit, vs $14 for UNH. UNH carries lower financial leverage with a 0.77x debt-to-equity ratio, signaling a more conservative balance sheet compared to CI's 0.78x.
| Metric | CICigna Corporation | UNHUnitedHealth Grou… |
|---|---|---|
| ROE (TTM)Return on equity | +14.6% | +14.0% |
| ROA (TTM)Return on assets | +3.9% | +4.6% |
| ROICReturn on invested capital | +10.5% | +9.3% |
| ROCEReturn on capital employed | +9.3% | +9.7% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 6 |
| Debt / EquityFinancial leverage | 0.78x | 0.77x |
| Net DebtTotal debt minus cash | $24.4B | $50.3B |
| Cash & Equiv.Liquid assets | $7.5B | $28.1B |
| Total DebtShort + long-term debt | $32.0B | $78.4B |
| Interest CoverageEBIT ÷ Interest expense | 6.88x | 4.67x |
Total Returns (with DRIP)
A $10,000 investment in CI five years ago would be worth $14,648 today (with dividends reinvested), compared to $9,845 for UNH. Over the past 12 months, CI leads with a -4.2% total return vs UNH's -36.4%. The 3-year compound annual growth rate (CAGR) favors CI at 1.6% vs UNH's -12.6% — a key indicator of consistent wealth creation.
| Metric | CICigna Corporation | UNHUnitedHealth Grou… |
|---|---|---|
| YTD ReturnYear-to-date | +3.8% | -12.8% |
| 1-Year ReturnPast 12 months | -4.2% | -36.4% |
| 3-Year ReturnCumulative with dividends | +4.9% | -33.3% |
| 5-Year ReturnCumulative with dividends | +46.5% | -1.5% |
| 10-Year ReturnCumulative with dividends | +125.7% | +191.5% |
| CAGR (3Y)Annualised 3-year return | +1.6% | -12.6% |
Risk & Volatility
CI is the less volatile stock with a 0.19 beta — it tends to amplify market swings less than UNH's 0.28 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CI currently trades 82.8% from its 52-week high vs UNH's 48.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | CICigna Corporation | UNHUnitedHealth Grou… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.19x | 0.28x |
| 52-Week HighHighest price in past year | $350.00 | $606.36 |
| 52-Week LowLowest price in past year | $239.51 | $234.60 |
| % of 52W HighCurrent price vs 52-week peak | +82.8% | +48.4% |
| RSI (14)Momentum oscillator 0–100 | 55.1 | 44.6 |
| Avg Volume (50D)Average daily shares traded | 1.3M | 8.2M |
Analyst Outlook
Wall Street rates CI as "Buy" and UNH as "Buy". Consensus price targets imply 31.4% upside for UNH (target: $385) vs 12.4% for CI (target: $326). For income investors, UNH offers the higher dividend yield at 5.18% vs CI's 1.91%.
| Metric | CICigna Corporation | UNHUnitedHealth Grou… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $325.83 | $385.38 |
| # AnalystsCovering analysts | 39 | 52 |
| Dividend YieldAnnual dividend ÷ price | +1.9% | +5.2% |
| Dividend StreakConsecutive years of raises | 5 | 25 |
| Dividend / ShareAnnual DPS | $5.53 | $15.20 |
| Buyback YieldShare repurchases ÷ mkt cap | +9.2% | +2.4% |
Historical Charts
Charts are rendered on first load. Hover for details.
Chart 1Total Return — 5 Years (Rebased to 100)
| Stock | Feb 20 | Feb 26 | Change |
|---|---|---|---|
| Cigna Corporation (CI) | 100 | 148.43 | +48.4% |
| UnitedHealth Group … (UNH) | 100 | 112.01 | +12.0% |
Cigna Corporation (CI) returned +46% over 5 years vs UnitedHealth Group … (UNH)'s -2%. A $10,000 investment in CI 5 years ago would be worth $14,648 today (including dividends reinvested).
Chart 2Revenue Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Cigna Corporation (CI) | $39.8B | $247.1B | +520.3% |
| UnitedHealth Group … (UNH) | $184.8B | $447.6B | +142.1% |
UnitedHealth Group Incorporated's revenue grew from $184.8B (2016) to $447.6B (2025) — a 10.3% CAGR.
Chart 3Net Margin Trend — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Cigna Corporation (CI) | 4.7% | 1.4% | -70.3% |
| UnitedHealth Group … (UNH) | 3.8% | 3.2% | -16.3% |
UnitedHealth Group Incorporated's net margin went from 4% (2016) to 3% (2025).
Chart 4P/E Ratio History — 9 Years
| Stock | 2017 | 2025 | Change |
|---|---|---|---|
| Cigna Corporation (CI) | 22.1 | 22.8 | +3.2% |
| UnitedHealth Group … (UNH) | 20.6 | 21.2 | +2.9% |
Cigna Corporation has traded in a 9x–23x P/E range over 8 years; current trailing P/E is ~24x. UnitedHealth Group Incorporated has traded in a 20x–33x P/E range over 9 years; current trailing P/E is ~19x.
Chart 5EPS Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Cigna Corporation (CI) | 7.19 | 12.12 | +68.6% |
| UnitedHealth Group … (UNH) | 7.25 | 15.58 | +114.9% |
UnitedHealth Group Incorporated's EPS grew from $7.25 (2016) to $15.58 (2025) — a 9% CAGR.
Chart 6Free Cash Flow — 5 Years
Cigna Corporation generated $9B FCF in 2024 (+48% vs 2021). UnitedHealth Group Incorporated generated $32B FCF in 2025 (+61% vs 2021).
CI vs UNH: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is CI or UNH a better buy right now?
UnitedHealth Group Incorporated (UNH) offers the better valuation at 18.8x trailing P/E (16.4x forward), making it the more compelling value choice. Analysts rate Cigna Corporation (CI) a "Buy" — based on 39 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CI or UNH?
On trailing P/E, UnitedHealth Group Incorporated (UNH) is the cheapest at 18.8x versus Cigna Corporation at 23.9x. On forward P/E, Cigna Corporation is actually cheaper at 9.6x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — CI or UNH?
Over the past 5 years, Cigna Corporation (CI) delivered a total return of +46.5%, compared to -1.5% for UnitedHealth Group Incorporated (UNH). A $10,000 investment in CI five years ago would be worth approximately $15K today (assuming dividends reinvested). Over 10 years, the gap is even starker: UNH returned +191.5% versus CI's +125.7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CI or UNH?
By beta (market sensitivity over 5 years), Cigna Corporation (CI) is the lower-risk stock at 0.19β versus UnitedHealth Group Incorporated's 0.28β — meaning UNH is approximately 50% more volatile than CI relative to the S&P 500. On balance sheet safety, UnitedHealth Group Incorporated (UNH) carries a lower debt/equity ratio of 77% versus 78% for Cigna Corporation — giving it more financial flexibility in a downturn.
05Which has better profit margins — CI or UNH?
UnitedHealth Group Incorporated (UNH) is the more profitable company, earning 3.2% net margin versus 1.4% for Cigna Corporation — meaning it keeps 3.2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UNH leads at 4.2% versus 3.8% for CI. At the gross margin level — before operating expenses — UNH leads at 18.5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is CI or UNH more undervalued right now?
On forward earnings alone, Cigna Corporation (CI) trades at 9.6x forward P/E versus 16.4x for UnitedHealth Group Incorporated — 6.9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for UNH: 31.4% to $385.38.
07Which pays a better dividend — CI or UNH?
All stocks in this comparison pay dividends. UnitedHealth Group Incorporated (UNH) offers the highest yield at 5.2%, versus 1.9% for Cigna Corporation (CI).
08Is CI or UNH better for a retirement portfolio?
For long-horizon retirement investors, Cigna Corporation (CI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.19), 1.9% yield, +125.7% 10Y return). Both have compounded well over 10 years (CI: +125.7%, UNH: +191.5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between CI and UNH?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. In terms of investment character: CI is a mid-cap quality compounder stock; UNH is a large-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that beat both.